In This Issue
BRAF Mutations in Non–Small-Cell Lung Cancer
Refining the Toxicity Profile of Crizotinib
Intensity-Modulated Radiotherapy for Lung Cancer
Biomarkers in Early-Stage Non–Small-Cell Lung Cancer
The IASLC Lung Cancer Staging Project
Patient-Reported Outcomes and Quality of Life in PROFILE 1007
Crizotinib Effects on Creatinine and Non-Creatinine–Based Measures of Glomerular Filtration Rate
A Novel Mechanism of EML4-ALK Rearrangement Mediated by Chromothripsis in a Patient-Derived Cell Line
A Functional Polymorphism in CSF1R Gene Is a Novel Susceptibility Marker for Lung Cancer among Never-Smoking Females
The Oncofetal Protein IMP3
A Common Polymorphism Within MSLN Affects miR-611 Binding Site and Soluble Mesothelin Levels in Healthy People
Clinical Characteristics and Course of 63 Patients with BRAF Mutant Lung Cancers
Multicenter Immunohistochemical ALK-Testing of Non–Small-Cell Lung Cancer Shows High Concordance after Harmonization of Techniques and Interpretation Criteria
Lung Stereotactic Body Radiation Therapy
Noninvasive Risk Stratification of Lung Adenocarcinoma using Quantitative Computed Tomography
Evaluation of Antitumor Activity Using Change in Tumor Size of the Survivin Antisense Oligonucleotide LY2181308 in Combination with Docetaxel for Second-Line Treatment of Patients with Non–Small-Cell Lung Cancer
Association of EPAS1 Gene rs4953354 Polymorphism with Susceptibility to Lung Adenocarcinoma in Female Japanese Non-Smokers
RET-Rearranged Lung Adenocarcinomas with Lymphangitic Spread, Psammoma Bodies, and Clinical Responses to Cabozantinib
Outcome of Multimodality Treatment for 188 Cases of Type B3 Thymoma
Development of Renal Cysts after Crizotinib Treatment in Advanced ALK-Positive Non–Small-Cell Lung Cancer
Successful Desensitization of Two Patients with ALK-Positive Lung Cancer and Hypersensitivity to Crizotinib
The Case of the Missed Chest Radiograph
Vocal Cord Paralysis after Stereotactic Body Radiation Therapy to the Left Lung Apex
First-Line Chemotherapy Treatment of Advanced Non–Small-Cell Lung Cancer
How to Minimize Harms of Lung Cancer Screening
Young Male with Fanconi Anemia and EGFR-Mutant Non–Small-Cell Lung Cancer